Literature DB >> 23764050

Structural determinants of arrestin functions.

Vsevolod V Gurevich1, Eugenia V Gurevich.   

Abstract

Arrestins are a small protein family with only four members in mammals. Arrestins demonstrate an amazing versatility, interacting with hundreds of different G protein-coupled receptor (GPCR) subtypes, numerous nonreceptor signaling proteins, and components of the internalization machinery, as well as cytoskeletal elements, including regular microtubules and centrosomes. Here, we focus on the structural determinants that mediate various arrestin functions. The receptor-binding elements in arrestins were mapped fairly comprehensively, which set the stage for the construction of mutants targeting particular GPCRs. The elements engaged by other binding partners are only now being elucidated and in most cases we have more questions than answers. Interestingly, even very limited and imprecise identification of structural requirements for the interaction with very few other proteins has enabled the development of signaling-biased arrestin mutants. More comprehensive understanding of the structural underpinning of different arrestin functions will pave the way for the construction of arrestins that can link the receptor we want to the signaling pathway of our choosing.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23764050      PMCID: PMC4514030          DOI: 10.1016/B978-0-12-394440-5.00003-6

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  175 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  Ligand-induced internalization and recycling of the human neuropeptide Y2 receptor is regulated by its carboxyl-terminal tail.

Authors:  Cornelia Walther; Stefanie Nagel; Luis E Gimenez; Karin Mörl; Vsevolod V Gurevich; Annette G Beck-Sickinger
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

3.  Arrestin-1 expression level in rods: balancing functional performance and photoreceptor health.

Authors:  X Song; S A Vishnivetskiy; J Seo; J Chen; E V Gurevich; V V Gurevich
Journal:  Neuroscience       Date:  2010-11-12       Impact factor: 3.590

4.  Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.

Authors:  Ellen Y T Chien; Wei Liu; Qiang Zhao; Vsevolod Katritch; Gye Won Han; Michael A Hanson; Lei Shi; Amy Hauck Newman; Jonathan A Javitch; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-11-19       Impact factor: 47.728

5.  Elucidation of inositol hexaphosphate and heparin interaction sites and conformational changes in arrestin-1 by solution nuclear magnetic resonance.

Authors:  Tiandi Zhuang; Sergey A Vishnivetskiy; Vsevolod V Gurevich; Charles R Sanders
Journal:  Biochemistry       Date:  2010-11-15       Impact factor: 3.162

6.  Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding.

Authors:  Timothy H Bayburt; Sergey A Vishnivetskiy; Mark A McLean; Takefumi Morizumi; Chih-Chin Huang; John J G Tesmer; Oliver P Ernst; Stephen G Sligar; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

7.  Monomeric rhodopsin is the minimal functional unit required for arrestin binding.

Authors:  Hisao Tsukamoto; Abhinav Sinha; Mark DeWitt; David L Farrens
Journal:  J Mol Biol       Date:  2010-04-22       Impact factor: 5.469

8.  Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.

Authors:  Søren G F Rasmussen; Hee-Jung Choi; Juan Jose Fung; Els Pardon; Paola Casarosa; Pil Seok Chae; Brian T Devree; Daniel M Rosenbaum; Foon Sun Thian; Tong Sun Kobilka; Andreas Schnapp; Ingo Konetzki; Roger K Sunahara; Samuel H Gellman; Alexander Pautsch; Jan Steyaert; William I Weis; Brian K Kobilka
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

9.  The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.

Authors:  Tony Warne; Rouslan Moukhametzianov; Jillian G Baker; Rony Nehmé; Patricia C Edwards; Andrew G W Leslie; Gebhard F X Schertler; Christopher G Tate
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

10.  Structure and function of an irreversible agonist-β(2) adrenoceptor complex.

Authors:  Daniel M Rosenbaum; Cheng Zhang; Joseph A Lyons; Ralph Holl; David Aragao; Daniel H Arlow; Søren G F Rasmussen; Hee-Jung Choi; Brian T Devree; Roger K Sunahara; Pil Seok Chae; Samuel H Gellman; Ron O Dror; David E Shaw; William I Weis; Martin Caffrey; Peter Gmeiner; Brian K Kobilka
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

View more
  27 in total

1.  Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes.

Authors:  Luis E Gimenez; Stefanie Babilon; Lizzy Wanka; Annette G Beck-Sickinger; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

Review 2.  Methodological advances: the unsung heroes of the GPCR structural revolution.

Authors:  Eshan Ghosh; Punita Kumari; Deepika Jaiman; Arun K Shukla
Journal:  Nat Rev Mol Cell Biol       Date:  2015-01-15       Impact factor: 94.444

Review 3.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

Review 4.  Spo0M: structure and function beyond regulation of sporulation.

Authors:  Luz Adriana Vega-Cabrera; Christopher D Wood; Liliana Pardo-López
Journal:  Curr Genet       Date:  2017-06-02       Impact factor: 3.886

5.  Arrestin makes T cells stop and become active.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  EMBO J       Date:  2014-02-06       Impact factor: 11.598

6.  Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors.

Authors:  X Edward Zhou; Yuanzheng He; Parker W de Waal; Xiang Gao; Yanyong Kang; Ned Van Eps; Yanting Yin; Kuntal Pal; Devrishi Goswami; Thomas A White; Anton Barty; Naomi R Latorraca; Henry N Chapman; Wayne L Hubbell; Ron O Dror; Raymond C Stevens; Vadim Cherezov; Vsevolod V Gurevich; Patrick R Griffin; Oliver P Ernst; Karsten Melcher; H Eric Xu
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

7.  Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.

Authors:  Xuanzhi Zhan; Alejandro Perez; Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-01-08       Impact factor: 4.315

Review 8.  Many faces of the GPCR-arrestin interaction.

Authors:  Kiae Kim; Ka Young Chung
Journal:  Arch Pharm Res       Date:  2020-08-14       Impact factor: 4.946

Review 9.  Structure and dynamics of GPCR signaling complexes.

Authors:  Daniel Hilger; Matthieu Masureel; Brian K Kobilka
Journal:  Nat Struct Mol Biol       Date:  2018-01-08       Impact factor: 15.369

Review 10.  Overview of different mechanisms of arrestin-mediated signaling.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Curr Protoc Pharmacol       Date:  2014-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.